These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 10435495)
41. Association of VEGF gene polymorphisms with sporadic Parkinson's disease in Chinese Han population. Wu Y; Zhang Y; Han X; Li X; Xue L; Xie A Neurol Sci; 2016 Dec; 37(12):1923-1929. PubMed ID: 27481110 [TBL] [Abstract][Full Text] [Related]
43. [Genetic polymorphism and susceptibility to occupational chronic manganism: a case-control study]. Zheng Y; He F; Chan P; Pan Z; Wang Z; Pan J; Zhou X Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Mar; 33(2):78-80. PubMed ID: 11864457 [TBL] [Abstract][Full Text] [Related]
44. [The alpha-synuclein gene microsatellite polymorphism and late-onset sporadic Parkinson's disease susceptibility]. Zhao XP; Zheng HM; Xie HJ; Ding SJ; Ren DM Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):339-41. PubMed ID: 15300629 [TBL] [Abstract][Full Text] [Related]
45. Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease. Maraganore DM; Farrer MJ; Hardy JA; McDonnell SK; Schaid DJ; Rocca WA Mov Disord; 2000 Jul; 15(4):714-9. PubMed ID: 10928584 [TBL] [Abstract][Full Text] [Related]
46. Association of CYP2D microsatellite polymorphism with Lewy body variant of Alzheimer's disease. Tanaka S; Chen X; Xia Y; Kang DE; Matoh N; Sundsmo M; Thomas RG; Katzman R; Thal LJ; Trojanowski JQ; Saitoh T; Ueda K; Masliah E Neurology; 1998 Jun; 50(6):1556-62. PubMed ID: 9633694 [TBL] [Abstract][Full Text] [Related]
47. CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease. Atkinson A; Singleton AB; Steward A; Ince PG; Perry RH; McKeith IG; Fairbairn AF; Edwardson JA; Daly AK; Morris CM Pharmacogenetics; 1999 Feb; 9(1):31-5. PubMed ID: 10208640 [TBL] [Abstract][Full Text] [Related]
48. Association of A313 G polymorphism (GSTP1*B) in the glutathione-S-transferase P1 gene with sporadic Parkinson's disease. Vilar R; Coelho H; Rodrigues E; Gama MJ; Rivera I; Taioli E; Lechner MC Eur J Neurol; 2007 Feb; 14(2):156-61. PubMed ID: 17250723 [TBL] [Abstract][Full Text] [Related]
49. Case-control study of the parkin gene in early-onset Parkinson disease. Clark LN; Afridi S; Karlins E; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K Arch Neurol; 2006 Apr; 63(4):548-52. PubMed ID: 16606767 [TBL] [Abstract][Full Text] [Related]
50. The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of Parkinson's disease: a meta-analysis. Christensen PM; Gøtzsche PC; Brøsen K Pharmacogenetics; 1998 Dec; 8(6):473-9. PubMed ID: 9918130 [TBL] [Abstract][Full Text] [Related]
51. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Smith CA; Gough AC; Leigh PN; Summers BA; Harding AE; Maraganore DM; Sturman SG; Schapira AH; Williams AC Lancet; 1992 Jun; 339(8806):1375-7. PubMed ID: 1350805 [TBL] [Abstract][Full Text] [Related]
52. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. Silvestri L; Sonzogni L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Leveri M; Cividini A; Mondelli MU; Civardi E; Silini EM Int J Cancer; 2003 Apr; 104(3):310-7. PubMed ID: 12569554 [TBL] [Abstract][Full Text] [Related]
53. Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease. Sinha R; Racette B; Perlmutter JS; Parsian A Parkinsonism Relat Disord; 2005 Sep; 11(6):341-7. PubMed ID: 16019250 [TBL] [Abstract][Full Text] [Related]
54. CYP2D6 genetic polymorphisms are associated with susceptibility to pituitary tumors. Gomes L; Lemos MC; Paiva I; Ribeiro C; Carvalheiro M; Regateiro FJ Acta Med Port; 2005; 18(5):339-43. PubMed ID: 16611538 [TBL] [Abstract][Full Text] [Related]
55. Further evidence that interactions between CYP2D6 and pesticide exposure increase risk for Parkinson's disease. Deng Y; Newman B; Dunne MP; Silburn PA; Mellick GD Ann Neurol; 2004 Jun; 55(6):897. PubMed ID: 15174030 [No Abstract] [Full Text] [Related]
56. ApoE and CYP2D6 polymorphism with and without parkinsonism-dementia complex in the people of Chamorro, guam. Chen X; Xia Y; Gresham LS; Molgaard CA; Thomas RG; Galasko D; Wiederholt WC; Saitoh T Neurology; 1996 Sep; 47(3):779-84. PubMed ID: 8797479 [TBL] [Abstract][Full Text] [Related]
57. The CYP2D6B allele is not overrepresented in a population of German patients with idiopathic Parkinson's disease. Gasser T; Müller-Myhsok B; Supala A; Zimmer E; Wieditz G; Wszolek ZK; Vieregge P; Bonifati V; Oertel WH J Neurol Neurosurg Psychiatry; 1996 Nov; 61(5):518-20. PubMed ID: 8937349 [TBL] [Abstract][Full Text] [Related]
58. Association between genetic polymorphism of angiotensin-converting enzyme gene and Parkinson's disease. Lin JJ; Yueh KC; Chang DC; Lin SZ J Neurol Sci; 2002 Jul; 199(1-2):25-9. PubMed ID: 12084438 [TBL] [Abstract][Full Text] [Related]
59. Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease. Bialecka M; Klodowska-Duda G; Honczarenko K; Gawrońska-Szklarz B; Opala G; Safranow K; Droździk M Parkinsonism Relat Disord; 2007 May; 13(4):224-9. PubMed ID: 17270484 [TBL] [Abstract][Full Text] [Related]
60. Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population. Bozina N; Granić P; Lalić Z; Tramisak I; Lovrić M; Stavljenić-Rukavina A Croat Med J; 2003 Aug; 44(4):425-8. PubMed ID: 12950145 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]